
Picodya is redefining in-vitro diagnostics with our innovative configurable, fully automated Matrix Platform that enables rapid, multiplex testing across molecular and immunoassay assays from minimal sample volumes. Our go-to-market strategy is built on two vectors: near-term adoption in research and clinical/LDT laboratories (RUO → LDT), followed by scalable FDA-cleared point-of-care panels that decentralize high-complexity diagnostics. Suc...